Position in AMGN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$39,045,589
+$578,885 QoQ
Shares Held
107,825
-1.4% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#250
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $708,681,337 across 15 Drug Manufacturers - General names. AMGN ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
181,813 | $218,071,984 | |
| 2 | ABBV |
AbbVie Inc.
|
566,381 | $142,524,114 | |
| 3 | JNJ |
Johnson & Johnson
|
486,640 | $123,591,960 | |
| 4 | MRK |
Merck & Co., Inc.
|
469,217 | $60,294,384 | |
| 5 | PFE |
Pfizer Inc
|
1,820,575 | $43,839,446 | |
| 6 | AMGN |
Amgen Inc
This page
|
107,825 | $39,045,589 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
434,411 | $25,030,761 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
144,124 | $18,208,626 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $39,045,589 | 107,825 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $38,466,704 | 109,327 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $35,220,519 | 107,606 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $29,752,063 | 105,429 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $30,271,110 | 108,417 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $33,724,041 | 108,246 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $28,220,014 | 108,272 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $35,064,503 | 108,825 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $34,292,012 | 109,752 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $34,451,054 | 121,170 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $34,849,555 | 120,997 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $32,252,543 | 120,005 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $24,621,795 | 110,899 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $26,577,511 | 109,938 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $24,688,685 | 94,002 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $21,062,503 | 93,445 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $22,560,722 | 92,728 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $22,189,403 | 91,760 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $20,267,997 | 90,092 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $18,823,140 | 88,517 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $20,398,706 | 83,687 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $19,842,348 | 79,749 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $18,227,827 | 79,279 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $20,986,245 | 82,571 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $20,591,049 | 87,302 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $17,331,387 | 85,490 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||